Virtus ETF Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $917K | Buy |
|
|||||
|
2025
Q2 | $67K | Hold |
|
|||||
|
2025
Q1 | $51.6K | Sell |
|
|||||
|
2024
Q4 | $372K | Sell |
|
|||||
|
2024
Q3 | $336K | Hold |
|
|||||
|
2024
Q2 | $355K | Buy |
|
|||||
|
2024
Q1 | $251K | Buy |
|
|||||
|
2023
Q4 | $364K | Sell |
|
|||||
|
2023
Q3 | $263K | Sell |
|
|||||
|
2023
Q2 | $341K | Sell |
|
|||||
|
2023
Q1 | $367K | Buy |
|
|||||
|
2022
Q4 | $305K | Buy |
|
|||||
|
2022
Q3 | $237K | Buy |
|
|||||
|
2022
Q2 | $201K | Sell |
|
|||||
|
2022
Q1 | $392K | Hold |
|
|||||
|
2021
Q4 | $377K | Sell |
|
|||||
|
2021
Q3 | $279K | Sell |
|
|||||
|
2021
Q2 | $447K | Buy |
|
|||||
|
2021
Q1 | $310K | Buy |
|
|||||
|
2020
Q4 | $624K | Sell |
|
|||||
|
2020
Q3 | $526K | Buy |
|
|||||
|
2020
Q2 | $566K | Sell |
|
|||||
|
2020
Q1 | $561K | Sell |
|
|||||
|
2019
Q4 | $616K | Sell |
|
|||||
|
2019
Q3 | $1.03M | Sell |
|
|||||
|
2019
Q2 | $892K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $505K | Buy |
|
|||||
|
2016
Q2 | $450K | Buy |
|
|||||
|
2016
Q1 | $206K | Sell |
|
|||||
|
2015
Q4 | $279K | Buy |
|